MediWound Ltd.

Good day, everyone, and welcome to MediWOON's first quarter 2023 earnings call. Today's conference is being recorded. At this time, I'd like to turn the floor over to Monique Cossie of Lifestyle Advisors. Ma'am, please go ahead.

Thank you, Operator, and welcome, everyone. Earlier today, Metawoon issued a press release announcing financial results for the first quarter ended March 31st, 2023. You may access that release on the company's website under the Investors tab. With us today are Ofer Gonen, Chief Executive Officer of Metawoon, Hani Luxemburg, Chief Financial Officer, and Barry Wolfenson, Executive Vice President of Strategy and Corporate Development. Following our prepared remarks, we will open the call for Q&A. Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to Meadowood's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those forecasted to the impact of many factors beyond the control of MediLoom. The company assumes no obligation to update or supplement any forward-looking statements. whether as a result of new information, future events, or otherwise. Participants are directed to cautionary notes set forth in today's press release, as well as the risk factors set forth in Meadowoon's annual report filed with the SEC for factors that could cause actual results to differ materially from those anticipated in the forward-looking statements. The conference call is the property of Meadowoon, and any recording or rebroadcast is expressly prohibited without the written consent of Meadowood. Now I'd like to turn the call over to Ofer Gonan, Chief Executive Officer of Meadowood. Ofer?

Thank you, Monique, and good morning, everyone. It's my pleasure to welcome all of you to our first quarter earnings conference call. I'm eager to share the substantial progress we have made this quarter. we are poised to launch NexoBREED in the U.S. market and initiate our pivotal Phase 3 SCREC study. These significant milestones highlight the strong momentum we are experiencing and set the foundation for a promising future. Allow me to introduce my newest colleagues who are joining me today. Ms. Hani Luxemburg, who has recently assumed the role of Chief Financial Officer, and Mr. Barry Wolfenson, our Executive Vice President of Strategy and Corporate Development. We are fortunate to have their expertise and leadership as we continue to advance our company forward. Kani officially became part of our team in the beginning of this month, ensuring seamless transition in our financial leadership. Barry, who joined us in March, has been diligently working on the expansion of our U.S. operations. I will now briefly hand over the call to both Hani and Barry, allowing them to personally introduce themselves. Hani, over to you.